Searle & Co. Viatris Inc Transaction History

Searle & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 01, 2023	SELL	$9.2 - $12.26 $74,032 - $98,656	-8,047 Reduced 28.73%	19,966 $192,000
Q4 2022 Feb 03, 2023	SELL	$8.72 - $11.56 $1,621 - $2,150	-186 Reduced 0.66%	28,013 $311,000
Q2 2022 Aug 03, 2022	SELL	$9.95 - $12.27 $88,555 - $109,203	-8,900 Reduced 23.99%	28,199 $295,000
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $158,922 - $249,480	-16,200 Reduced 30.39%	37,099 $404,000
Q4 2021 Jan 19, 2022	BUY	$12.09 - $14.68 $30,829 - $37,434	2,550 Added 5.02%	53,299 $721,000
Q3 2021 Oct 08, 2021	SELL	$13.25 - $15.13 $980 - $1,119	-74 Reduced 0.15%	50,749 $688,000
Q1 2021 May 12, 2021	BUY	$13.59 - $18.54 $202,327 - $276,023	14,888 Added 41.43%	50,823 $710,000
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $513,870 - $673,421	35,935 New	35,935 $673,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.